Literature DB >> 11385248

Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer.

J Standop1, M B Schneider, A Ulrich, P M Pour.   

Abstract

The silent course of pancreatic cancer and its explosive fatal outcome have hindered studies of tumor histogenesis and the identification of early biochemical and genetic alterations that could help to diagnose the disease at a curable stage and develop therapeutic strategies. Experimental animal models provide important tools to assess risk factors, as well as preventive and therapeutic possibilities. Although several pancreatic cancer models presently exist, only models that closely resemble human tumors in morphological, clinical, and biological aspects present useful media for preclinical studies. Because an estimated 70% of human tumors are induced by carcinogens and because a significant association has been found between cigarette smoking and pancreatic cancer, chemically induced models are of particular value. Moreover, in such models the etiology, modifying factors, effects of diets, and naturally occurring products can be studied and early diagnostic, preventive, and therapeutic possibilities sought out. Many of the existing models are described in this review, and the advantages and shortcomings of each model and their clinical implications are discussed. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385248     DOI: 10.1159/000050650

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

Review 1.  Transgenic models of pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.

Authors:  Jing-Ting Jiang; Chang-Ping Wu; Hai-Feng Deng; Ming-Yang Lu; Jun Wu; Hong-Yu Zhang; Wen-Hui Sun; Mei Ji
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

3.  Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia.

Authors:  Pamela L Crowell; C Max Schmidt; Michele T Yip-Schneider; Jesse J Savage; Dean A Hertzler; William O Cummings
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

4.  Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice.

Authors:  L Li; Y-Z Yuan; J Lu; L Xia; Y Zhu; Y-P Zhang; M-M Qiao
Journal:  Gut       Date:  2005-11-15       Impact factor: 23.059

Review 5.  Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer.

Authors:  J D Liao; N V Adsay; F Khannani; D Grignon; A Thakur; F H Sarkar
Journal:  Histol Histopathol       Date:  2007-06       Impact factor: 2.303

Review 6.  Cigarette smoke-induced pancreatic damage: experimental data.

Authors:  Uwe A Wittel; Ulrich T Hopt; Surinder K Batra
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

7.  Selective expression of CYP2A13 in human pancreatic α-islet cells.

Authors:  Yu Guo; Liang-Ru Zhu; Gang Lu; Hui Wang; Jun-Yan Hong
Journal:  Drug Metab Dispos       Date:  2012-07-13       Impact factor: 3.922

8.  Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease.

Authors:  Mami Takahashi; Mika Hori; Michihiro Mutoh; Keiji Wakabayashi; Hitoshi Nakagama
Journal:  Cancers (Basel)       Date:  2011-02-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.